Track CADL and 10,000+ stocks
Create a free account to build watchlists, compare peers, and value any stock.
- Build and track watchlists
- Compare against peers
- Earnings & price alerts
No credit card required
Create a free account to build watchlists, compare peers, and value any stock.
No credit card required
CADL - Candel Therapeutics Inc (CADL) has a shares outstanding of 54.90M, up 54.4% over the past year.
Shares Outstanding
54.90M
Dilution %
+193.35%
Annual Change
+54.36%
| Year | Shares | Change |
|---|---|---|
| 2025 | 54.90M | +54.36% |
| 2024 | 35.56M | +22.72% |
| 2023 | 28.98M | +0.28% |
| 2022 | 28.90M | +23.90% |
| 2021 | 23.33M | +24.64% |
| 2020 | 18.71M | - |
| Quarter | Shares | Change |
|---|---|---|
| Q4 2025 | 54.90M | +0.01% |
| Q3 2025 | 54.89M | +6.61% |
| Q2 2025 | 51.49M | +62.56% |
| Q1 2025 | 31.68M | -10.94% |
| Q4 2024 | 35.56M | +11.09% |
| Q3 2024 | 32.01M | +7.15% |
| Q2 2024 | 29.88M | +2.33% |
| Q1 2024 | 29.20M | +0.75% |
| Q4 2023 | 28.98M | +0.21% |
| Q3 2023 | 28.92M | +0.00% |
| Q2 2023 | 28.92M | +0.00% |
| Q1 2023 | 28.92M | +0.07% |
| Q4 2022 | 28.90M | +0.03% |
| Q3 2022 | 28.89M | +0.28% |
| Q2 2022 | 28.81M | +0.42% |
| Q1 2022 | 28.69M | +23.00% |
| Q4 2021 | 23.33M | +0.00% |
| Q3 2021 | 23.33M | -5.93% |
| Q2 2021 | 24.80M | +32.50% |
| Q1 2021 | 18.71M | +0.00% |
| Q4 2020 | 18.71M | +0.00% |
| Q3 2020 | 18.71M | +0.00% |
| Q2 2020 | 18.71M | +0.00% |
| Q1 2020 | 18.71M | - |
Shares outstanding is the total number of a company's shares currently held by all its shareholders. A shrinking share count usually reflects buybacks that raise each remaining share's claim on earnings, while a rising count can signal dilution.